Mandate

Vinge advises Dianovator AB on directed share issue

September 15, 2017

Vinge has advised Dianovator AB in connection with a directed share issue to finance the company’s research and development.

Dianovator AB is developing a patient-specific decision support system for improved glycemic control by optimized insulin dosing.

Dianovator AB was assisted by Kristoffer Franzkeit.

Related

Vinge has advised Triton in connection with sale of shares in Ambea AB (publ)

In total, 8.4 million shares were placed at a price of SEK 43.50 per share, corresponding to a total value of approximately SEK 365 million.
November 29, 2023

Vinge represents Lassie AB in a capital raising of SEK 260 million

Vinge has advised the pet insurance broker Lassie AB in connection with a capital raising of SEK 260 million in order to continue the expansion of the business.
November 29, 2023

Vinge advises Expedition Growth Capital in connection with its investment in Factbird 

Expedition Growth Capital, together with the Export and Investment Fund of Denmark (EIFO), have completed its investment in the Danish tech company Factbird. Vinge acted for Expedition Growth Capital in connection with the investment.
November 27, 2023